Logo image of ELA

ENVELA CORP (ELA) Stock Fundamental Analysis

NYSEARCA:ELA - NYSE Arca - US29402E1029 - Common Stock - Currency: USD

6.08  -0.09 (-1.46%)

Fundamental Rating

7

Taking everything into account, ELA scores 7 out of 10 in our fundamental rating. ELA was compared to 121 industry peers in the Specialty Retail industry. Both the health and profitability get an excellent rating, making ELA a very profitable company, without any liquidiy or solvency issues. ELA is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, ELA could be worth investigating further for growth and quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year ELA was profitable.
In the past year ELA had a positive cash flow from operations.
Each year in the past 5 years ELA has been profitable.
Each year in the past 5 years ELA had a positive operating cash flow.
ELA Yearly Net Income VS EBIT VS OCF VS FCFELA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

With an excellent Return On Assets value of 9.22%, ELA belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
The Return On Equity of ELA (13.32%) is better than 70.25% of its industry peers.
ELA's Return On Invested Capital of 10.31% is fine compared to the rest of the industry. ELA outperforms 72.73% of its industry peers.
ELA had an Average Return On Invested Capital over the past 3 years of 12.62%. This is in line with the industry average of 13.07%.
Industry RankSector Rank
ROA 9.22%
ROE 13.32%
ROIC 10.31%
ROA(3y)13.47%
ROA(5y)14.62%
ROE(3y)21.28%
ROE(5y)27.31%
ROIC(3y)12.62%
ROIC(5y)13.55%
ELA Yearly ROA, ROE, ROICELA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

Looking at the Profit Margin, with a value of 3.89%, ELA is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
In the last couple of years the Profit Margin of ELA has grown nicely.
Looking at the Operating Margin, with a value of 4.73%, ELA is in the better half of the industry, outperforming 66.94% of the companies in the same industry.
In the last couple of years the Operating Margin of ELA has grown nicely.
ELA has a Gross Margin of 24.35%. This is in the lower half of the industry: ELA underperforms 74.38% of its industry peers.
In the last couple of years the Gross Margin of ELA has grown nicely.
Industry RankSector Rank
OM 4.73%
PM (TTM) 3.89%
GM 24.35%
OM growth 3Y-12.44%
OM growth 5Y2.74%
PM growth 3Y-19.3%
PM growth 5Y2.02%
GM growth 3Y3.52%
GM growth 5Y4.39%
ELA Yearly Profit, Operating, Gross MarginsELA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

9

2. Health

2.1 Basic Checks

ELA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
ELA has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ELA has been reduced compared to 5 years ago.
ELA has a better debt/assets ratio than last year.
ELA Yearly Shares OutstandingELA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ELA Yearly Total Debt VS Total AssetsELA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

ELA has an Altman-Z score of 7.57. This indicates that ELA is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ELA (7.57) is better than 97.52% of its industry peers.
The Debt to FCF ratio of ELA is 3.28, which is a good value as it means it would take ELA, 3.28 years of fcf income to pay off all of its debts.
ELA has a better Debt to FCF ratio (3.28) than 73.55% of its industry peers.
ELA has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.18, ELA is doing good in the industry, outperforming 66.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 3.28
Altman-Z 7.57
ROIC/WACC1.12
WACC9.21%
ELA Yearly LT Debt VS Equity VS FCFELA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

2.3 Liquidity

ELA has a Current Ratio of 4.51. This indicates that ELA is financially healthy and has no problem in meeting its short term obligations.
ELA's Current ratio of 4.51 is amongst the best of the industry. ELA outperforms 98.35% of its industry peers.
A Quick Ratio of 2.31 indicates that ELA has no problem at all paying its short term obligations.
ELA has a Quick ratio of 2.31. This is amongst the best in the industry. ELA outperforms 93.39% of its industry peers.
Industry RankSector Rank
Current Ratio 4.51
Quick Ratio 2.31
ELA Yearly Current Assets VS Current LiabilitesELA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

7

3. Growth

3.1 Past

ELA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.67%, which is quite good.
The Earnings Per Share has been growing by 20.12% on average over the past years. This is a very strong growth
Looking at the last year, ELA shows a quite strong growth in Revenue. The Revenue has grown by 15.71% in the last year.
Measured over the past years, ELA shows a quite strong growth in Revenue. The Revenue has been growing by 17.07% on average per year.
EPS 1Y (TTM)16.67%
EPS 3Y-12.25%
EPS 5Y20.12%
EPS Q2Q%42.86%
Revenue 1Y (TTM)15.71%
Revenue growth 3Y8.56%
Revenue growth 5Y17.07%
Sales Q2Q%21.07%

3.2 Future

The Earnings Per Share is expected to grow by 24.39% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 8.74% on average over the next years. This is quite good.
EPS Next Y29.28%
EPS Next 2Y24.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.28%
Revenue Next 2Y8.74%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ELA Yearly Revenue VS EstimatesELA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ELA Yearly EPS VS EstimatesELA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 21.71, ELA is valued on the expensive side.
Based on the Price/Earnings ratio, ELA is valued a bit cheaper than the industry average as 67.77% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.45. ELA is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 15.72 indicates a correct valuation of ELA.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ELA indicates a somewhat cheap valuation: ELA is cheaper than 65.29% of the companies listed in the same industry.
ELA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.90.
Industry RankSector Rank
PE 21.71
Fwd PE 15.72
ELA Price Earnings VS Forward Price EarningsELA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

ELA's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ELA is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 39.25
EV/EBITDA 14.19
ELA Per share dataELA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ELA has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ELA's earnings are expected to grow with 24.39% in the coming years.
PEG (NY)0.74
PEG (5Y)1.08
EPS Next 2Y24.39%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ELA!.
Industry RankSector Rank
Dividend Yield N/A

ENVELA CORP

NYSEARCA:ELA (7/3/2025, 7:19:45 PM)

6.08

-0.09 (-1.46%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)05-08 2025-05-08/dmh
Earnings (Next)07-30 2025-07-30/amc
Inst Owners13.65%
Inst Owner Change5.35%
Ins Owners49.42%
Ins Owner Change0.2%
Market Cap158.08M
Analysts80
Price Target9.69 (59.37%)
Short Float %1.53%
Short Ratio2.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)30.13%
Min EPS beat(2)18.81%
Max EPS beat(2)41.44%
EPS beat(4)4
Avg EPS beat(4)31.9%
Min EPS beat(4)18.81%
Max EPS beat(4)48.51%
EPS beat(8)5
Avg EPS beat(8)9.86%
EPS beat(12)8
Avg EPS beat(12)25.22%
EPS beat(16)12
Avg EPS beat(16)26.31%
Revenue beat(2)2
Avg Revenue beat(2)9.94%
Min Revenue beat(2)2.14%
Max Revenue beat(2)17.74%
Revenue beat(4)4
Avg Revenue beat(4)15.97%
Min Revenue beat(4)2.14%
Max Revenue beat(4)22.84%
Revenue beat(8)6
Avg Revenue beat(8)3.52%
Revenue beat(12)9
Avg Revenue beat(12)4.74%
Revenue beat(16)12
Avg Revenue beat(16)7.62%
PT rev (1m)18.75%
PT rev (3m)18.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-35%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.68%
Valuation
Industry RankSector Rank
PE 21.71
Fwd PE 15.72
P/S 0.84
P/FCF 39.25
P/OCF 20.99
P/B 2.87
P/tB 3.32
EV/EBITDA 14.19
EPS(TTM)0.28
EY4.61%
EPS(NY)0.39
Fwd EY6.36%
FCF(TTM)0.15
FCFY2.55%
OCF(TTM)0.29
OCFY4.76%
SpS7.26
BVpS2.12
TBVpS1.83
PEG (NY)0.74
PEG (5Y)1.08
Profitability
Industry RankSector Rank
ROA 9.22%
ROE 13.32%
ROCE 13.18%
ROIC 10.31%
ROICexc 14.95%
ROICexgc 17.82%
OM 4.73%
PM (TTM) 3.89%
GM 24.35%
FCFM 2.13%
ROA(3y)13.47%
ROA(5y)14.62%
ROE(3y)21.28%
ROE(5y)27.31%
ROIC(3y)12.62%
ROIC(5y)13.55%
ROICexc(3y)17.69%
ROICexc(5y)18.43%
ROICexgc(3y)21.62%
ROICexgc(5y)22.7%
ROCE(3y)16.14%
ROCE(5y)17.45%
ROICexcg growth 3Y-9.57%
ROICexcg growth 5Y-0.97%
ROICexc growth 3Y-7.64%
ROICexc growth 5Y1.09%
OM growth 3Y-12.44%
OM growth 5Y2.74%
PM growth 3Y-19.3%
PM growth 5Y2.02%
GM growth 3Y3.52%
GM growth 5Y4.39%
F-Score7
Asset Turnover2.37
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 3.28
Debt/EBITDA 0.93
Cap/Depr 211.79%
Cap/Sales 1.86%
Interest Coverage 23.43
Cash Conversion 71.1%
Profit Quality 54.86%
Current Ratio 4.51
Quick Ratio 2.31
Altman-Z 7.57
F-Score7
WACC9.21%
ROIC/WACC1.12
Cap/Depr(3y)141.77%
Cap/Depr(5y)313.83%
Cap/Sales(3y)1.17%
Cap/Sales(5y)2.18%
Profit Quality(3y)69.25%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3Y-12.25%
EPS 5Y20.12%
EPS Q2Q%42.86%
EPS Next Y29.28%
EPS Next 2Y24.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.71%
Revenue growth 3Y8.56%
Revenue growth 5Y17.07%
Sales Q2Q%21.07%
Revenue Next Year11.28%
Revenue Next 2Y8.74%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.46%
EBIT growth 3Y-4.94%
EBIT growth 5Y20.28%
EBIT Next Year58.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-57.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-21.44%
OCF growth 3Y53.73%
OCF growth 5YN/A